Published in Strahlenther Onkol on September 01, 2007
Review of advanced catheter technologies in radiation oncology brachytherapy procedures. Cancer Manag Res (2015) 0.85
Myofibroblastic sarcoma of the base of tongue. Case report and review of the literature. Strahlenther Onkol (2009) 0.84
Stereotactic interstitial radiosurgery for intracranial Rosai-Dorfman disease. A novel therapeutic approach. Strahlenther Onkol (2009) 0.84
Intraoperative radiotherapy (IORT) with low-energy photons as a boost in patients with early-stage oral cancer with the indications for postoperative radiotherapy : treatment feasibility and preliminary results. Strahlenther Onkol (2010) 0.82
Perioperative intensity-modulated brachytherapy for refractory orbital rhabdomyosarcomas in children. Strahlenther Onkol (2009) 0.82
Pulsed dose rate brachytherapy of lip cancer. J Contemp Brachytherapy (2013) 0.79
Molecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugs. Cell Mol Life Sci (2016) 0.77
High-dose-rate and pulsed-dose-rate brachytherapy for oral cavity cancer and oropharynx cancer. J Contemp Brachytherapy (2010) 0.75
A review of the clinical experience in pulsed dose rate brachytherapy. Br J Radiol (2015) 0.75
Bcl-B expression in human epithelial and nonepithelial malignancies. Clin Cancer Res (2008) 1.16
Relationship between acute and late normal tissue injury after postoperative radiotherapy in endometrial cancer. Int J Radiat Oncol Biol Phys (2002) 0.97
Prediction of mesorectal nodal metastases after chemoradiation for rectal cancer: results of a randomised trial: implication for subsequent local excision. Radiother Oncol (2005) 0.93
Gene copy numbers of HER family in breast cancer. J Cancer Res Clin Oncol (2007) 0.92
Factors determining acute normal tissue reactions during postoperative radiotherapy in endometrial cancer: analysis of 317 consecutive cases. Radiother Oncol (2003) 0.89
Clinical relevance of hemoglobin level in cervical cancer patients administered definitive radiotherapy. Acta Oncol (2006) 0.84
Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer. J Thorac Oncol (2015) 0.82
Pattern of care in locally advanced breast cancer: focus on local therapy. Breast (2010) 0.82
[The occurrence of microorganisms in intraoral abscesses]. Med Dosw Mikrobiol (2005) 0.79
Immunohistochemical prediction of brain metastases in patients with advanced breast cancer: the role of Rad51. Breast (2013) 0.78
Time without symptoms and toxicity (TWIST) analysis of adjuvant radiation therapy for endometrial cancer. Radiother Oncol (2004) 0.77
Immunohistochemical Predictors of Bone Metastases in Breast Cancer Patients. Pathol Oncol Res (2015) 0.76
J. Jassem on A. Mayer, et al. Primary radiotherapy of stage IIA/B-IIIB cervical carcinoma. A comparison of continuous versus sequential regimens. Strahlenther Onkol 2004;180:209-15 (No. 4). Strahlenther Onkol (2005) 0.75
EPR/alanine dosimetry in LDR brachytherapy--a feasibility study. Radiat Prot Dosimetry (2006) 0.75
Changes in lateral dimensions of irradiated volume and their impact on the accuracy of dose delivery during radiotherapy for head and neck cancer. Radiother Oncol (2006) 0.75
[Brachytherapy--own, preliminary experiences in the treatment of head and neck neoplasms with the use of pulsed brachytherapy]. Wiad Lek (2002) 0.75
P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma. Cancer (2004) 0.75
[The role of radiotherapy in the management of esophageal cancer]. Pol Merkur Lekarski (2005) 0.75
Endocrine disrupting chemicals as potential risk factor for estrogen-dependent cancers. Pol Arch Med Wewn (2016) 0.75
[Chemosensitivity testing in ovarian cancer--prospects for the future]. Ginekol Pol (2014) 0.75